Misoprostol Administered by Epithelial Routes
Authors:
- Karen R. MeckstrothKMKaren R. Meckstroth
- Amy K. WhitakerAWAmy K. Whitaker
- Suzanne BertischSuzanne Bertisch
- Alisa B. GoldbergAGAlisa B. Goldberg
- Philip D. DarneyPDPhilip D. Darney
- 1 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 108 (3, Part 1) , 582-590
Abstract
To quantify and compare serum levels and uterine effects following vaginal (dry), vaginal (moistened), buccal, and rectal misoprostol administration. Forty women seeking elective abortion between 6 and 12 6/7 weeks were randomly assigned to receive 400 mug of misoprostol by one of four routes. A 2.5-mm pressure monitoring catheter was placed through the cervix to the uterine fundus to record uterine tone and activity during the 5-hour observation period. Serum levels of misoprostol acid were measured at 15 and 30 minutes, then every 30 minutes. The four groups were similar in age, race or ethnicity, body mass index, parity, and gestation. Serum levels after vaginal, vaginal moistened and buccal administration rose gradually, peaked between 15 and 120 minutes and fell slowly. Vaginal and vaginal moistened routes produced higher peak serum levels than buccal and rectal (445.9 and 427.1 compared with 264.8 and 202.2 pg/mL; P = .03) and higher serum concentration area under the curve at 5 hours (1,025.0 and 1279.4 compared with 519.6 and 312.5 pg-hr/mL; P < .001). Uterine tone and activity, however, were similar for buccal and the two vaginal routes. After rectal administration, serum levels peaked earlier (P < .001) then dropped more abruptly, and peak uterine tone (P < .001) and total activity (P = .04) were lower than after the other routes. Although serum levels were lower for buccal compared with the vaginal routes, the three routes produced similar uterine tone and activity. Rectal administration produced lower uterine tone and activity. Vaginal serum levels were two to three and a half times higher than those observed in prior misoprostol pharmacokinetic studies.Keywords
This publication has 22 references indexed in Scilit:
- A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimesterHuman Reproduction, 2004
- Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: a randomized comparisonContraception, 2004
- A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortionAmerican Journal of Obstetrics and Gynecology, 2004
- A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestationHuman Reproduction, 2003
- Pilot study on the use of sublingual misoprostol in termination of pregnancy up to 7 weeks gestationContraception, 2003
- A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriagesHuman Reproduction, 2003
- Buccal misoprostol as cervical preparation for second trimester pregnancy terminationContraception, 2002
- Sublingual compared with oral misoprostol in term labour induction: a randomised controlled trialBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Medical management of early fetal demise using sublingual misoprostolBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Buccal versus intravaginal misoprostol administration for cervical ripeningAmerican Journal of Obstetrics and Gynecology, 2002